Quantum-Si (NASDAQ:QSI) Rating Reiterated by HC Wainwright

Quantum-Si (NASDAQ:QSI)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research note issued to investors on Friday, Benzinga reports. They currently have a $4.00 target price on the stock. HC Wainwright’s price objective points to a potential upside of 118.58% from the stock’s current price.

Quantum-Si Price Performance

QSI opened at $1.83 on Friday. Quantum-Si has a 12 month low of $1.12 and a 12 month high of $3.90. The stock has a market capitalization of $259.44 million, a P/E ratio of -2.69 and a beta of 3.04. The business has a 50 day simple moving average of $1.79 and a 200-day simple moving average of $1.68.

Quantum-Si (NASDAQ:QSI) last released its earnings results on Thursday, February 29th. The company reported ($0.16) EPS for the quarter, meeting analysts’ consensus estimates of ($0.16). The company had revenue of $0.40 million during the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative return on equity of 30.65% and a negative net margin of 8,868.76%. Research analysts anticipate that Quantum-Si will post -0.87 EPS for the current year.

Insiders Place Their Bets

In related news, CFO Jeffry R. Keyes purchased 50,000 shares of Quantum-Si stock in a transaction dated Tuesday, March 5th. The stock was bought at an average cost of $1.61 per share, for a total transaction of $80,500.00. Following the transaction, the chief financial officer now owns 50,000 shares in the company, valued at $80,500. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Quantum-Si news, CEO Jeffrey Alan Hawkins bought 25,000 shares of the company’s stock in a transaction on Thursday, March 14th. The stock was purchased at an average cost of $1.76 per share, for a total transaction of $44,000.00. Following the acquisition, the chief executive officer now owns 25,000 shares of the company’s stock, valued at approximately $44,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jeffry R. Keyes purchased 50,000 shares of Quantum-Si stock in a transaction on Tuesday, March 5th. The stock was acquired at an average cost of $1.61 per share, for a total transaction of $80,500.00. Following the acquisition, the chief financial officer now directly owns 50,000 shares of the company’s stock, valued at $80,500. The disclosure for this purchase can be found here. Over the last three months, insiders have purchased 85,000 shares of company stock worth $141,900. 30.04% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. ARK Investment Management LLC grew its holdings in shares of Quantum-Si by 7.4% during the fourth quarter. ARK Investment Management LLC now owns 15,519,322 shares of the company’s stock worth $31,194,000 after buying an additional 1,071,105 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. grew its stake in Quantum-Si by 424.5% in the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 8,532,917 shares of the company’s stock worth $14,165,000 after acquiring an additional 6,905,932 shares during the period. Pathstone Family Office LLC acquired a new position in Quantum-Si in the 3rd quarter valued at $43,000. Cookson Peirce & Co. Inc. acquired a new position in Quantum-Si in the 4th quarter valued at $101,000. Finally, Knollwood Investment Advisory LLC purchased a new position in shares of Quantum-Si during the 3rd quarter worth $498,000. 39.90% of the stock is currently owned by institutional investors and hedge funds.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.